Lantheus Holdings, Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $1.5 | $1.5 | $1.3 | $0.9 | $0.4 |
| Operating income | $0.3 | $0.5 | $0.4 | $<0.1 | -$0.1 |
| Net income | $0.2 | $0.3 | $0.3 | $<0.1 | -$0.1 |
| Balance Sheet | |||||
| Total debt | — | — | $0.6 | $0.6 | $0.2 |
| Cash Flow Statement | |||||
| Free cash flow | $0.4 | $0.5 | $0.3 | $<0.1 | $0.1 |
| Share repurchases | $0.3 | $0.1 | $0.0 | $0.1 | $0.0 |
Shares outstanding 65.3M · Free float 92.9%
Annual filing data through FY ended December 31, 2025; float as of September 30, 2026.
Earnings
Other Coverage
October 2, 2026
Deal Scrutiny
Curium refiles for Lantheus Holdings, Inc. (LNTH) acquisition
September 28, 2026
QBook
Stronger demand supports expansion as pricing diverges
August 14, 2026
Industry Earnings Roundup
Healthcare Earnings: Demand Surges, Costs Bite Back
August 3, 2026
Deals
Curium to Buy Lantheus in $8 Billion Cash-and-CVR Deal